• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005 - 2016年美国糖尿病照护级联评估

Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016.

作者信息

Kazemian Pooyan, Shebl Fatma M, McCann Nicole, Walensky Rochelle P, Wexler Deborah J

机构信息

Medical Practice Evaluation Center, Massachusetts General Hospital, Boston.

Division of General Internal Medicine, Massachusetts General Hospital, Boston.

出版信息

JAMA Intern Med. 2019 Oct 1;179(10):1376-1385. doi: 10.1001/jamainternmed.2019.2396.

DOI:10.1001/jamainternmed.2019.2396
PMID:31403657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6692836/
Abstract

IMPORTANCE

Treatment advances in diabetes can meaningfully improve outcomes only if they effectively reach the populations at risk.

OBJECTIVES

To evaluate whether the cascade of US diabetes care, defined as diabetes diagnosis, linkage to care, and achievement of individual and combined treatment targets, improved from 2005 to 2016 and to investigate potential disparities in US diabetes care.

DESIGN, SETTING, AND PARTICIPANTS: Nationally representative, serial cross-sectional studies included in the 2005-2016 National Health and Nutrition Examination Survey were evaluated. Data on nonpregnant US adults (age ≥18 years) with diabetes who had reported fasting for 9 or more hours (n = 1742 diagnosed and 746 undiagnosed) were included. Data analysis was performed from August 1, 2018, to May 10, 2019.

EXPOSURES

Time period (2005-2008, 2009-2012, and 2013-2016), age, sex, race/ethnicity, health insurance, and educational level incorporated into logistic regression models predicting odds of target achievement.

MAIN OUTCOMES AND MEASURES

Proportion of participants overall and stratified by age, sex, and race/ethnicity who were linked to diabetes care and met glycemic (hemoglobin A1c <7.0%-8.5%, depending on age and complications), blood pressure (<140/90 mm Hg), cholesterol level (low-density lipoprotein cholesterol <100 mg/dL), and smoking abstinence targets and a composite of all targets.

RESULTS

In 2013-2016, of 1742 US adults with diagnosed diabetes, 94% (95% CI, 92%-96%) were linked to diabetes care; 64% (95% CI, 58%-69%) met hemoglobin A1c level, 70% (95% CI, 64%-75%) met blood pressure level, and 57% (95% CI, 51%-62%) met cholesterol level targets; 85% were nonsmokers (95% CI, 82%-88%); and 23% (95% CI, 17%-29%) achieved the composite goal. Results were similar in 2005-2008 (composite 23%) and in 2009-2012 (composite 25%). There was no significant improvement in diagnosis or target achievement during the study period. Compared with middle-aged adults (45-64 years) with diagnosed diabetes, older patients (≥65 years) had higher odds (adjusted odds ratio [aOR], 1.70; 95% CI, 1.17-2.48) and younger adults (18-44 years) had lower odds (aOR, 0.53; 95% CI, 0.29-0.97) of meeting the composite target. Women had lower odds of achieving the composite target than men (aOR, 0.60; 95% CI, 0.45-0.80). Non-Hispanic black individuals vs non-Hispanic white individuals had lower odds of achieving the composite target (aOR, 0.57; 95% CI, 0.39-0.83). Having health insurance was the strongest predictor of linkage to diabetes care (aOR, 3.96; 95% CI, 2.34-6.69).

CONCLUSIONS AND RELEVANCE

It appears that the diabetes care cascade in the United States has not significantly improved between 2005 and 2016. This study's findings suggest that gaps in diabetes care that were present in 2005, particularly among younger adults (18-44 years), women, and nonwhite individuals, persist.

摘要

重要性

糖尿病治疗的进展只有在有效惠及高危人群时,才能切实改善治疗效果。

目的

评估2005年至2016年期间美国糖尿病照护的级联情况(定义为糖尿病诊断、与照护的关联以及个体和综合治疗目标的达成)是否有所改善,并调查美国糖尿病照护中潜在的差异。

设计、背景和参与者:对纳入2005 - 2016年国家健康与营养检查调查的具有全国代表性的系列横断面研究进行评估。纳入了报告禁食9小时或更长时间的美国成年糖尿病患者(年龄≥18岁)的数据(n = 1742例已诊断和746例未诊断)。数据分析于2018年8月1日至2019年5月10日进行。

暴露因素

时间段(2005 - 2008年、2009 - 2012年和2013 - 2016年)、年龄、性别、种族/民族、医疗保险和教育水平纳入逻辑回归模型,以预测目标达成的几率。

主要结局和指标

总体参与者以及按年龄、性别和种族/民族分层的参与者中,与糖尿病照护相关联且达到血糖(糖化血红蛋白<7.0% - 8.5%,取决于年龄和并发症)、血压(<140/90 mmHg)、胆固醇水平(低密度脂蛋白胆固醇<100 mg/dL)和戒烟目标以及所有目标综合指标的比例。

结果

在2013 - 2016年期间,1742例已诊断糖尿病的美国成年人中,94%(95%CI,92% - 96%)与糖尿病照护相关联;64%(95%CI,58% - 69%)达到糖化血红蛋白水平,70%(95%CI,64% - 75%)达到血压水平,57%(95%CI,51% - 62%)达到胆固醇水平目标;85%为非吸烟者(95%CI,82% - 88%);23%(95%CI,17% - 29%)实现了综合目标。2005 - 2008年(综合目标达成率23%)和2009 - 2012年(综合目标达成率25%)的结果相似。研究期间,诊断或目标达成情况没有显著改善。与已诊断糖尿病的中年成年人(45 - 64岁)相比,老年患者(≥65岁)达到综合目标的几率更高(调整优势比[aOR],1.70;95%CI,1.17 - 2.48),而年轻成年人(18 - 44岁)达到综合目标的几率更低(aOR,0.53;95%CI,0.29 - 0.97)。女性达到综合目标的几率低于男性(aOR,0.60;95%CI,0.45 - 0.80)。非西班牙裔黑人个体与非西班牙裔白人个体相比,达到综合目标的几率更低(aOR,0.57;95%CI,0.39 - 0.83)。拥有医疗保险是与糖尿病照护相关联的最强预测因素(aOR,3.96;95%CI,2.34 - 6.69)。

结论与意义

2005年至2016年期间,美国糖尿病照护的级联情况似乎没有显著改善。本研究结果表明,2005年存在的糖尿病照护差距,尤其是在年轻成年人(18 - 44岁)、女性和非白人个体中,仍然存在。

相似文献

1
Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016.2005 - 2016年美国糖尿病照护级联评估
JAMA Intern Med. 2019 Oct 1;179(10):1376-1385. doi: 10.1001/jamainternmed.2019.2396.
2
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018.1999 - 2018年美国成年人糖尿病患病率及糖尿病危险因素控制趋势
JAMA. 2021 Jun 25;326(8):1-13. doi: 10.1001/jama.2021.9883.
3
Association of Race and Ethnicity With Glycemic Control and Hemoglobin A Levels in Youth With Type 1 Diabetes.1型糖尿病青少年的种族与血糖控制及糖化血红蛋白水平的关联
JAMA Netw Open. 2018 Sep 7;1(5). doi: 10.1001/jamanetworkopen.2018.1851.
4
Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin, 1988-2020.美国成人糖尿病患者使用胰岛素的血糖控制和严重高血糖趋势及差异,1988-2020 年。
JAMA Netw Open. 2022 Dec 1;5(12):e2247656. doi: 10.1001/jamanetworkopen.2022.47656.
5
A cascade of care for diabetes in the United States: visualizing the gaps.美国糖尿病的连续护理:可视化差距。
Ann Intern Med. 2014 Nov 18;161(10):681-9. doi: 10.7326/M14-0019.
6
Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.美国有医用大麻法律的州大麻合法化后,种族和民族之间在大麻使用方面的差异。
JAMA Netw Open. 2021 Sep 1;4(9):e2127002. doi: 10.1001/jamanetworkopen.2021.27002.
7
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.美国成年人高血压患者血压控制趋势,1999-2000 年至 2017-2018 年。
JAMA. 2020 Sep 22;324(12):1190-1200. doi: 10.1001/jama.2020.14545.
8
Reach and Use of Diabetes Prevention Services in the United States, 2016-2017.2016-2017 年美国糖尿病预防服务的提供和使用情况。
JAMA Netw Open. 2019 May 3;2(5):e193160. doi: 10.1001/jamanetworkopen.2019.3160.
9
Self-reported Eye Care Use Among US Adults Aged 50 to 80 Years.美国50至80岁成年人自我报告的眼部护理使用情况。
JAMA Ophthalmol. 2019 Sep 1;137(9):1061-1066. doi: 10.1001/jamaophthalmol.2019.1927.
10
Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.与临床试验邀请和参与相关的人口统计学和健康行为因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2127792. doi: 10.1001/jamanetworkopen.2021.27792.

引用本文的文献

1
Diabetologists' Knowledge and Prescription of Physical Activity in Southeast Europe.东南欧糖尿病专家对体育活动的认知与处方
Medicina (Kaunas). 2025 Jul 10;61(7):1244. doi: 10.3390/medicina61071244.
2
Evaluating Digital Health Solutions in Diabetes and the Role of Patient-Reported Outcomes: Targeted Literature Review.评估糖尿病数字健康解决方案及患者报告结局的作用:针对性文献综述
JMIR Diabetes. 2025 Jun 4;10:e52909. doi: 10.2196/52909.
3
Patients' perspectives about sharing information with providers on social needs during pregnancy: a qualitative study.患者对孕期与医护人员分享社会需求信息的看法:一项定性研究。
BMC Health Serv Res. 2025 May 21;25(1):737. doi: 10.1186/s12913-025-12666-0.
4
Cardiovascular risk management in adults with diagnosed diabetes in Mexico from 2016-2023: A retrospective analysis of nationally representative surveys.2016 - 2023年墨西哥确诊糖尿病成年人的心血管风险管理:基于全国代表性调查的回顾性分析
medRxiv. 2025 May 5:2024.09.18.24313926. doi: 10.1101/2024.09.18.24313926.
5
One-Year Outcomes of SADI-S in Chinese Patients with Type 2 Diabetes and BMI < 35 kg/m: A Single-Center Retrospective Study.中国2型糖尿病且体重指数(BMI)< 35kg/m²患者接受SADI-S手术的一年结局:一项单中心回顾性研究
Obes Surg. 2025 Apr 26. doi: 10.1007/s11695-025-07872-y.
6
Real world evidence of insulin and biosimilar insulin therapy-Opportunities to improve adherence, outcomes and cost-effectiveness.胰岛素及生物类似物胰岛素治疗的真实世界证据——改善依从性、治疗效果和成本效益的机遇
Diabetes Obes Metab. 2025 Apr 15. doi: 10.1111/dom.16386.
7
Transportation Barriers and Diabetes Outcomes: A Longitudinal Analysis.交通障碍与糖尿病结局:一项纵向分析
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251320709. doi: 10.1177/21501319251320709.
8
Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study.代谢管理中心项目中中国2型糖尿病成年患者的生物医学结局和心血管风险:一项纵向比较研究。
J Diabetes Investig. 2025 May;16(5):884-892. doi: 10.1111/jdi.14414. Epub 2025 Feb 1.
9
What Primary Care Clinicians Need to Know About Once-Weekly Insulins.基层医疗临床医生需要了解的关于每周一次胰岛素的知识。
Fed Pract. 2024 Nov;41(Suppl 6):S47-S52. doi: 10.12788/fp.0536. Epub 2024 Nov 20.
10
A patient choice-driven lifestyle intervention lowers HbA1c in type 2 diabetes: A feasibility study.一项由患者选择驱动的生活方式干预可降低2型糖尿病患者的糖化血红蛋白:一项可行性研究。
Physiol Rep. 2025 Jan;13(2):e70163. doi: 10.14814/phy2.70163.